Frequently Asked Questions about Merck & Co., Inc. (MRK)

Name: Merck & Co., Inc. (MRK) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Merck & Co., Inc. (MRK) do?

Accepted Answer

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, ...

Question 2

Is Merck & Co., Inc. (MRK) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of MRK reveals an Altman Z-Score of 4.02 and a Piotroski F-Score of 6/9. These metrics, combined with its 5-year revenue trend ($65.01B most recent), help investors decide if MRK fits their risk profile.

Question 3

What is the current P/E ratio for MRK?

Accepted Answer

As of the latest trading session, Merck & Co., Inc. (MRK) has a trailing P/E ratio of 16.49.

Question 4

Who is the CEO of Merck & Co., Inc.?

Accepted Answer

The current Chief Executive Officer of Merck & Co., Inc. is Robert Davis.

Question 5

What was MRK's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Merck & Co., Inc. reported annual revenues of $65.01B (2025), $64.17B (2024), $60.12B (2023), $59.28B (2022), $48.70B (2021) respectively.

Question 6

Does MRK pay a dividend?

Accepted Answer

Merck & Co., Inc. currently pays a dividend to its shareholders, with a trailing dividend yield of 2.75%.

Question 7

How much debt and cash flow does MRK have?

Accepted Answer

In its latest reporting period, Merck & Co., Inc. generated $12.36B in Free Cash Flow against a total debt load of $50.53B.

Question 8

What is the Price-to-Book (P/B) ratio of Merck & Co., Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Merck & Co., Inc. (MRK) is currently 5.72.

Question 9

What is the Price-to-Sales (P/S) ratio of MRK?

Accepted Answer

Based on trailing twelve-month data, Merck & Co., Inc. (MRK) trades at a Price-to-Sales (P/S) ratio of 4.60.

Question 10

What is Merck & Co., Inc.'s Return on Equity (ROE)?

Accepted Answer

Merck & Co., Inc. (MRK) has a Return on Equity (ROE) of 36.19%, representing its profitability relative to shareholder equity.

Period	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt
2025-12	136.9B	84.2B	52.7B	50.5B	36B
2024-12	117.1B	70.7B	46.4B	38.3B	25B
2023-12	106.7B	69B	37.6B	36.3B	29.4B
2022-12	109.2B	63.1B	46.1B	32B	19.3B
2021-12	105.7B	67.4B	38.3B	34.6B	26.5B

Period	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt
2025-12	136.9B	84.2B	52.7B	50.5B	36B
2024-12	117.1B	70.7B	46.4B	38.3B	25B
2023-12	106.7B	69B	37.6B	36.3B	29.4B
2022-12	109.2B	63.1B	46.1B	32B	19.3B
2021-12	105.7B	67.4B	38.3B	34.6B	26.5B